Ruzotolimod - Roche
Alternative Names: RG-7854; RO 7020531Latest Information Update: 02 Jun 2025
At a glance
- Originator Roche
- Class Acetates; Alcohols; Amines; Antivirals; Ketones; Pyrimidines; Small molecules; Thiazoles
- Mechanism of Action Toll-like receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 15 Nov 2024 Efficacy data from a phase II trial in Hepatitis B presented at the Liver Meeting 2024: 75th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2024)
- 08 Nov 2024 Discontinued - Phase-I for Hepatitis B in Hong Kong, Italy, Netherlands, Taiwan, Bulgaria, Thailand (PO)
- 08 Nov 2024 Discontinued - Phase-II for Hepatitis B (Combination therapy, Treatment-experienced) in United Kingdom, New Zealand, Canada, Hong Kong, Spain, Taiwan, Thailand, South Korea, China, Bulgaria, Chile, France, USA, Belgium, Romania (PO)